Ranitidine and cimetidine differ in their in vitro and in vivo effects on human colonic cancer growth

British Journal of Cancer

Volumn 73, Issue 7, 1996, Pages 872-876

  Lawson, J A ^a   Adams, W J ^a   Morris, D L ^a  

^a ST GEORGE HOSPITAL   (Australia)

Author keywords

Cimetidine; Colon cancer; Histamine; Ranitidine

Indexed keywords

CIMETIDINE; CYCLIC AMP; GROWTH FACTOR; HISTAMINE; HISTAMINE H2 RECEPTOR ANTAGONIST; RANITIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL GROWTH; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029875254     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.155     Document Type: Article

References (26)

1. ADAMS WJ, LAWSON JA, NICHOLSON SE, COOK TA AND MORRIS DL. (1993). The growth of carcinogen-induced colon cancer in rats is inhibited by cimetidine. Eur. J. Surg. Oncol., 19, 332-325.
2. ADAMS WJ, LAWSON JA AND MORRIS DL. (1994). Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut, 35, 1632-1636.
3. ADAMS WJ AND MORRIS DL. (1994). Short-course cimetidine and survival with colorectal cancer. Lancet, 1, 1768-69.
4. ALLEN JI, SYROPOULOS HJ, GRANT B, EAGON JC AND KAY NE. (1987). Cimetidine modulates natural killer cell function of patients with chronic lymphocytic leukemia. J. Lab. Clin. Med., 109, 396-401.
5. BRANDES LJ AND LA BELLA FS. (1993). Identification of intracellular histamine receptors (Hic) that regulate cell proliferation. In Histamine in Normal and Cancer Cell Proliferation. Advances in the Biosciences. Garcia-Caballero M, Brandes LJ and Hosoda S. (eds.), 89, 31-41. Pergamon Press: Oxford.
6. DURRANT LG, ROBINS RA, PIMM MV, PERKINS AC, ARMITAGE NC, HARDCASTLE JD AND BALDWIN RW. (1986). Antigenicity of newly established colorectal carcinoma cell lines. Br. J. Cancer, 53, 37-45.
7. EUHUS D, HUDD C, LAREGINA MC AND JOHNSON FE. (1986). Tumour measurement in the nude mouse. J. Surg. Oncol., 31, 229-234.
8. GIFFORD R AND TILBERG A. (1987). Histamine type-2 receptor antagonist immune modulation II. Cimetidine and ranitidine increase interleukin-2 production. Surgery, 102, 242-247.
9. HALM KB, KIM WH, LEE SI, KANG JK AND PARK IS. (1995). Comparison of immunomodulative effects of the histamine-2 receptor antagonists cimetidine, ranitidine, and famotidine on peripheral blood mononuclear cells in gastric cancer patients. Scand. J. Gastroenterol., 30, 265-271.
10. 2 receptor-mediated regulation of human natural killer cell activity. J. Immunol., 137, 656-660.
11. KIKUCHI Y, OOMORI K AND KATO K (1985). Effects of cimetidine on growth and immune function in nude mice bearing human ovarian carcinoma. J. Natl. Cancer Inst., 74, 495-498.
12. KUSYK CJ, MCNEIL NO AND JOHNSON LR. (1986). Stimulation of growth of a colon cancer cell line by Gastrim. Am. J. Physiol., 251, G597-601.
13. 2 receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations. Clin. Pharmacokinet., 20, 218-236.
14. MATSUMOTO S. (1995). Cimetidine and survival with colorectal cancer. Lancet, 346, 115.
15. NIELSON HJ, MOESGAARD F AND KEHLET H. (1989a). Ranitidine for prevention of postoperative suppression of delayed hypersensitivity. Am. J. Surg., 157, 291-294.
16. NIELSON HJ, PEDERSEN BK, MOESGAARD F, HAAHR PM AND KEHLET H. (1989b). Effect of ranitidine on postoperative suppression of natural killer cell activity and delayed hypersensitivity. Acta Chir Scand., 155, 377-382.
17. OSBAND ME, HAMILTON D, SHEN Y-J, COHEN E, SHLESINGER M, LAVEN P, BROWN A AND MCCAFFREY R. (1981). Successful tumour immunotherapy with cimetidine in mice. Lancet, 1, 636-638.
18. SEAMON KB AND DALY JW. (1981). Forskolin, a unique diterpene activator of cyclic AMP generating systems. J. Cyclic Nucleotide Res., 7, 201-224.
19. 2 antagonists. Agents Actions, 16, 195-198.
20. SVENDSEN LB, ROSS C, KNIGGE U, EREDERKSENLT J, GRAVESEN P, KJAEGARD J, KLUKE M, STIMPEL H, SPORSO BH. (1995). Cimetidine as an adjuvant treatment in colorectal cancer. A double-blind randomised pilot study. Dis. Colon Rectum, 38, 514-518.
21. TONNESEN H, KNIGGES U, BULOW S, DAMM P, FISCHERMAN K AND HESSELFELD P. (1988). Effect of cimetidine on survival after gastric cancer. Lancet, 2, 990-991.
22. 2 receptor antagonists. Anticancer Res., 3, 7-10.
23. WATSON SA, WILKINSON LJ, ROBERTSON JFR AND HARDCASTLE JD. (1993). Effect of histamine on the growth of human gastrointestinal tumours, reversal by cimetidine. Gut, 34, 1091-1096.
24. 2 receptors on human melanoma cells. Biochem Biophys Res Commun., 151, 518-523.
25. WHITEHEAD RH, ZHANG HH AND HAYWARD IP (1992). Retention of tissue-specific phenotype in a panel of colon carcinoma cell lines. Relationship to clinical correlates. Immunol. Cell Biol., 70, 227-236.
26. 2 receptor antagonist. Gut, 21, 187-191.